- Home
- BXP vs RVTY Comparison
BXP vs RVTY Comparison
Compare BXP & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXP
- RVTY
- Stock Information
- Founded
- BXP 1970
- RVTY 1937
- Country
- BXP United States
- RVTY United States
- Employees
- BXP N/A
- RVTY N/A
- Industry
- BXP Real Estate Investment Trusts
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- BXP Real Estate
- RVTY Industrials
- Exchange
- BXP Nasdaq
- RVTY Nasdaq
- Market Cap
- BXP 11.4B
- RVTY 9.9B
- IPO Year
- BXP 1997
- RVTY N/A
- Fundamental
- Price
- BXP $70.72
- RVTY $92.87
- Analyst Decision
- BXP Buy
- RVTY Buy
- Analyst Count
- BXP 17
- RVTY 13
- Target Price
- BXP $77.88
- RVTY $112.92
- AVG Volume (30 Days)
- BXP 1.7M
- RVTY 1.3M
- Earning Date
- BXP 10-28-2025
- RVTY 10-27-2025
- Dividend Yield
- BXP 3.96%
- RVTY 0.30%
- EPS Growth
- BXP N/A
- RVTY N/A
- EPS
- BXP N/A
- RVTY 1.99
- Revenue
- BXP $3,425,025,000.00
- RVTY $2,813,367,000.00
- Revenue This Year
- BXP $2.83
- RVTY $5.37
- Revenue Next Year
- BXP $2.27
- RVTY $3.07
- P/E Ratio
- BXP N/A
- RVTY $47.57
- Revenue Growth
- BXP 2.42
- RVTY 3.37
- 52 Week Low
- BXP $54.22
- RVTY $81.36
- 52 Week High
- BXP $84.75
- RVTY $128.29
- Technical
- Relative Strength Index (RSI)
- BXP 45.60
- RVTY 50.20
- Support Level
- BXP $68.01
- RVTY $88.48
- Resistance Level
- BXP $73.03
- RVTY $95.79
- Average True Range (ATR)
- BXP 1.73
- RVTY 2.81
- MACD
- BXP 0.02
- RVTY -0.21
- Stochastic Oscillator
- BXP 40.31
- RVTY 44.15
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.